John G.F. Cleland
National Institutes of Health
1299 Papers
11.2K Citations
John G.F. Cleland is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Heart failure & Medicine. The author has an hindex of 137, co-authored 1172 publications. Previous affiliations of John G.F. Cleland include Northwestern University & Imperial College London.
Chat about Author
Papers
Myocardial remodelling after withdrawing therapy for heart failure in patients with recovered dilated cardiomyopathy: insights from TRED-HF
Brian P Halliday,Ruth Owen,John Gregson,Vassilios S. Vassiliou,Xiuyu Chen,Ricardo Wage,Amrit Lota,Zohya Khalique,Upasana Tayal,Daniel Hammersley,Richard E. Jones,A. John Baksi,Martin R. Cowie,John G.F. Cleland,John G.F. Cleland,Dudley J. Pennell,Sanjay K Prasad +16 more
TL;DR: To characterize adverse ventricular remodelling after withdrawing therapy in recovered dilated cardiomyopathy (DCM) and to assess the role of EMT in this remodelling.
23
Declining In-Hospital Mortality and Increasing Heart Failure Incidence in Elderly Patients With First Myocardial Infarction
TL;DR: A decreasing overall mortality rate but an increasing incidence of heart failure (HF), especially late-onset HF, in a large cohort of patients with a first myocardial infarction in Alberta between 1994 and 2000 is reported.
23
Cardiac output does not limit submaximal exercise capacity in patients with chronic heart failure.
TL;DR: The effect of submaximal exercise on CO and other haemodynamic variables in patients with CHF is determined using a validated non‐invasive inert gas rebreathing system.
23
What is the optimal medical management of ischaemic heart failure
TL;DR: There is no evidence, yet, that revascularisation improves prognosis in patients with heart failure, even in patients who are demonstrated to have extensive myocardial hibernation, and on current evidence,Revascularisation should be reserved for the relief of angina.
23